Market Cap 4.18M
Revenue (ttm) 40,000.00
Net Income (ttm) -8.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -20,300.00%
Debt to Equity Ratio 0.00
Volume 35,500
Avg Vol 172,402
Day's Range N/A - N/A
Shares Out 1.23M
Stochastic %K 28%
Beta 1.47
Analysts Strong Buy
Price Target $30.00

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, which is in phase 1 for undisclosed indication;...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 22 884 1555
Fax: 41 22 884 1556
Address:
Chemin des Mines, 9, Geneva, Switzerland
TrendyTickers
TrendyTickers Sep. 12 at 11:58 AM
0 · Reply
mikekaren
mikekaren Sep. 2 at 3:32 PM
$ADXN The chart may not look pretty right now, but I’m watching the catalyst, not just today’s price. NTX-253 Phase 1 data has been expected around this period, and September 17 is a date I’m keeping on my radar. Nothing is guaranteed, but positive safety/pharmacology results could change the picture quickly. Until then, patience. 🤞
0 · Reply
flybyme
flybyme Sep. 1 at 11:05 AM
$ADXN All quite here again, whats new same old story
0 · Reply
mikekaren
mikekaren Aug. 28 at 2:36 PM
$ADXN forward guidance is dead 
0 · Reply
mikekaren
mikekaren Aug. 28 at 2:34 PM
$ADXN blah speech nothing burger, 
0 · Reply
mikekaren
mikekaren Aug. 28 at 2:14 PM
$ADXN Fed is speaking this morning and the market is listening closely. So far the message sounds cautious on inflation and rates, so expect some volatility. I’m watching the Nasdaq, Treasury yields and especially the chips. Don’t let the first move fool you — let the market digest the comments first. Could get interesting this morning.
0 · Reply
mikekaren
mikekaren Aug. 28 at 1:08 PM
$ADXN I went digging through CEO Tim Dyer’s disclosed ownership history looking specifically for insider selling. I couldn’t find evidence of him dumping his personal ADXN shares during the recent period. The filings show his core share position remained intact. Important distinction: the company raising capital/selling treasury shares is NOT the same thing as the CEO personally selling his stake.Not saying this guarantees anything again about the upcoming results, but with everything we’ve been watching, I’d rather see the CEO holding than heading for the exit.
0 · Reply
mikekaren
mikekaren Aug. 28 at 11:07 AM
$ADXN I went through the new 13D instead of just looking at the headline numbers. Dyer reports 16.85M ordinary shares owned, plus 2.25M shares underlying options currently exercisable. Remember, 120 ordinary shares = 1 ADXN ADS, so those option numbers aren’t 2.25M Nasdaq shares. The options are compensation and have a CHF 0.05 exercise price. Most importantly, the filing says no share transactions by Dyer in the last 60 days other than what’s disclosed. Not saying this guarantees anything — but I don’t see the CEO dumping into the recent move. To me, that’s a positive.
0 · Reply
Golferhack12
Golferhack12 Aug. 27 at 8:13 PM
$ADXN do we know what price they sold the shares at today they raised 2.8 million does anybody know I can't see any press release that has the price per share
0 · Reply
mikekaren
mikekaren Aug. 26 at 2:09 PM
$ADXN Something my dad taught me a long time ago when I was a kid: always be good to the people around you—it keeps you honest and keeps you humble. I try to carry that into trading too. When I’m fortunate enough to make a profit, I like to leave about 20% of that profit in the stock for the long term. I look at it as leaving a little tip on the table. 😂 Nobody wins every time, and nothing is guaranteed. But when the table treats you well, sometimes you tip the dealer and stay in the game. 🎲 Good luck to everyone holding. Let’s see where this thing takes us. 🤞
0 · Reply
Latest News on ADXN
Addex Therapeutics Earnings Call Transcript: Q1 2026

Jun 25, 2026, 10:00 AM EDT - 2 months ago

Addex Therapeutics Earnings Call Transcript: Q1 2026


Addex Therapeutics Quarterly report: Q1 2026

Jun 25, 2026, 10:00 AM EDT - 2 months ago

Addex Therapeutics Quarterly report: Q1 2026


Addex Therapeutics Earnings release: Q1 2026

Jun 25, 2026, 10:00 AM EDT - 2 months ago

Addex Therapeutics Earnings release: Q1 2026


Addex Therapeutics Releases Q1 2026 Financial Results

2026-06-25T10:30:56.000Z - 2 months ago

Addex Therapeutics Releases Q1 2026 Financial Results


Addex Convenes Annual General Meeting 2026

Fri, 05 Jun 2026 01:00:00 -0400 - 3 months ago

Addex Convenes Annual General Meeting 2026


Addex Therapeutics Earnings Call Transcript: H2 2025

Apr 30, 2026, 10:00 AM EDT - 4 months ago

Addex Therapeutics Earnings Call Transcript: H2 2025


Addex Therapeutics Annual report: H2 2025

Apr 30, 2026, 10:00 AM EDT - 4 months ago

Addex Therapeutics Annual report: H2 2025


Addex Therapeutics Earnings release: H2 2025

Apr 30, 2026, 10:00 AM EDT - 4 months ago

Addex Therapeutics Earnings release: H2 2025


Addex Therapeutics Earnings release: H2 2025

Apr 30, 2026, 10:00 AM EDT - 4 months ago

Addex Therapeutics Earnings release: H2 2025


Addex Therapeutics Annual report: H2 2025

Apr 30, 2026, 10:00 AM EDT - 4 months ago

Addex Therapeutics Annual report: H2 2025


Addex Therapeutics announces GABAB PAM candidate data

2026-04-29T09:35:53.000Z - 4 months ago

Addex Therapeutics announces GABAB PAM candidate data


Addex Reports Strong Anti-Tussive For GABAB PAM Candidate

2026-04-21T09:09:28.000Z - 4 months ago

Addex Reports Strong Anti-Tussive For GABAB PAM Candidate


Addex Therapeutics Ltd – ADR trading resumes

2026-03-18T16:05:59.000Z - 5 months ago

Addex Therapeutics Ltd – ADR trading resumes


Addex Therapeutics Ltd – ADR trading resumes

2026-01-13T17:31:18.000Z - 8 months ago

Addex Therapeutics Ltd – ADR trading resumes


Addex Therapeutics spin-out Neurosterix starts NTX-253 study

2026-01-07T10:10:23.000Z - 8 months ago

Addex Therapeutics spin-out Neurosterix starts NTX-253 study


Addex Therapeutics Earnings Call Transcript: Q3 2025

Dec 4, 2025, 10:00 AM EST - 9 months ago

Addex Therapeutics Earnings Call Transcript: Q3 2025


Addex Therapeutics Quarterly report: Q3 2025

Dec 4, 2025, 10:00 AM EST - 9 months ago

Addex Therapeutics Quarterly report: Q3 2025


Earnings Scheduled For December 4, 2025

2025-12-04T11:11:11.000Z - 9 months ago

Earnings Scheduled For December 4, 2025


Addex Therapeutics files to sell $150M in ordinary shares

2025-11-19T21:05:43.000Z - 9 months ago

Addex Therapeutics files to sell $150M in ordinary shares


Addex Therapeutics Registration statement: Registration Filing

Nov 19, 2025, 7:00 AM EST - 9 months ago

Addex Therapeutics Registration statement: Registration Filing


Addex Therapeutics Earnings Call Transcript: H1 2025

Oct 1, 2025, 10:00 AM EDT - 11 months ago

Addex Therapeutics Earnings Call Transcript: H1 2025


Addex Therapeutics Quarterly report: H1 2025

Oct 1, 2025, 10:00 AM EDT - 11 months ago

Addex Therapeutics Quarterly report: H1 2025


Earnings Scheduled For September 30, 2025

2025-09-30T08:32:10.000Z - 11 months ago

Earnings Scheduled For September 30, 2025


Addex Therapeutics Slips To Q2 Net Loss With Lower Income

2025-09-30T07:34:43.000Z - 11 months ago

Addex Therapeutics Slips To Q2 Net Loss With Lower Income


Addex Appoints Bank of New York Mellon as Depositary Bank

Sep 23, 2025, 1:00 AM EDT - 11 months ago

Addex Appoints Bank of New York Mellon as Depositary Bank


Addex Therapeutics Slides: Corporate Presentation

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Addex Therapeutics Slides: Corporate Presentation


Addex Therapeutics Ltd – ADR trading resumes

2025-06-20T13:46:04.000Z - 1 year ago

Addex Therapeutics Ltd – ADR trading resumes


Addex Therapeutics Earnings Call Transcript: Q1 2025

Jun 19, 2025, 10:00 AM EDT - 1 year ago

Addex Therapeutics Earnings Call Transcript: Q1 2025


Addex Therapeutics Quarterly report: Q1 2025

Jun 19, 2025, 10:00 AM EDT - 1 year ago

Addex Therapeutics Quarterly report: Q1 2025


Addex Convenes Annual General Meeting 2025

Tue, 03 Jun 2025 01:00:00 -0400 - 1 year ago

Addex Convenes Annual General Meeting 2025


Addex Therapeutics Earnings Call Transcript: H2 2024

Apr 25, 2025, 10:00 AM EDT - 1 year ago

Addex Therapeutics Earnings Call Transcript: H2 2024


Addex Therapeutics Annual report: H2 2024

Apr 25, 2025, 10:00 AM EDT - 1 year ago

Addex Therapeutics Annual report: H2 2024


Addex Therapeutics Annual report: H2 2024

Apr 25, 2025, 10:00 AM EDT - 1 year ago

Addex Therapeutics Annual report: H2 2024


Addex Therapeutics Slides: Corporate Presentation

Apr 25, 2025, 2:00 AM EDT - 1 year ago

Addex Therapeutics Slides: Corporate Presentation


Addex Therapeutics regains rights to ADX71149

2025-04-17T09:25:56.000Z - 1 year ago

Addex Therapeutics regains rights to ADX71149

JNJ


Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Apr 17, 2025, 1:00 AM EDT - 1 year ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149


Addex Therapeutics Earnings Call Transcript: Q3 2024

Nov 22, 2024, 10:00 AM EST - 1 year ago

Addex Therapeutics Earnings Call Transcript: Q3 2024


Addex Therapeutics Quarterly report: Q3 2024

Nov 22, 2024, 10:00 AM EST - 1 year ago

Addex Therapeutics Quarterly report: Q3 2024


Addex Therapeutics Earnings Call Transcript: H1 2024

Sep 30, 2024, 10:00 AM EDT - 1 year ago

Addex Therapeutics Earnings Call Transcript: H1 2024


Addex Therapeutics Quarterly report: H1 2024

Sep 30, 2024, 10:00 AM EDT - 1 year ago

Addex Therapeutics Quarterly report: H1 2024


Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 10:47 AM EDT - 2 years ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday


Addex's Partner Discontinues ADX71149 development in Epilepsy

Jul 22, 2024, 1:00 AM EDT - 2 years ago

Addex's Partner Discontinues ADX71149 development in Epilepsy


Addex Therapeutics Earnings Call Transcript: Q1 2024

Jun 6, 2024, 10:00 AM EDT - 2 years ago

Addex Therapeutics Earnings Call Transcript: Q1 2024


Addex Therapeutics Quarterly report: Q1 2024

Jun 6, 2024, 10:00 AM EDT - 2 years ago

Addex Therapeutics Quarterly report: Q1 2024


Addex Convenes Annual General Meeting 2024

Jun 5, 2024, 1:00 AM EDT - 2 years ago

Addex Convenes Annual General Meeting 2024


Addex to Present at Bio€quity Europe 2024

May 8, 2024, 1:00 AM EDT - 2 years ago

Addex to Present at Bio€quity Europe 2024


Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 29, 2024, 1:00 AM EDT - 2 years ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study


Addex to Present at the Swiss Biotech Day 2024

Apr 19, 2024, 1:00 AM EDT - 2 years ago

Addex to Present at the Swiss Biotech Day 2024


Addex Therapeutics Earnings Call Transcript: H2 2023

Apr 18, 2024, 10:00 AM EDT - 2 years ago

Addex Therapeutics Earnings Call Transcript: H2 2023


Addex Therapeutics Annual report: H2 2023

Apr 18, 2024, 10:00 AM EDT - 2 years ago

Addex Therapeutics Annual report: H2 2023


Addex Therapeutics Annual report: H2 2023

Apr 18, 2024, 10:00 AM EDT - 2 years ago

Addex Therapeutics Annual report: H2 2023


Addex to Present at the Bio-Europe Spring 2024 Conference

Mar 14, 2024, 2:00 AM EDT - 2 years ago

Addex to Present at the Bio-Europe Spring 2024 Conference


Addex to Present at the Swiss Equities Baader Conference

Jan 9, 2024, 1:00 AM EST - 2 years ago

Addex to Present at the Swiss Equities Baader Conference


Addex to Present at Biotech Showcase™ 2024

Jan 5, 2024, 1:30 AM EST - 2 years ago

Addex to Present at Biotech Showcase™ 2024


TrendyTickers
TrendyTickers Sep. 12 at 11:58 AM
0 · Reply
mikekaren
mikekaren Sep. 2 at 3:32 PM
$ADXN The chart may not look pretty right now, but I’m watching the catalyst, not just today’s price. NTX-253 Phase 1 data has been expected around this period, and September 17 is a date I’m keeping on my radar. Nothing is guaranteed, but positive safety/pharmacology results could change the picture quickly. Until then, patience. 🤞
0 · Reply
flybyme
flybyme Sep. 1 at 11:05 AM
$ADXN All quite here again, whats new same old story
0 · Reply
mikekaren
mikekaren Aug. 28 at 2:36 PM
$ADXN forward guidance is dead 
0 · Reply
mikekaren
mikekaren Aug. 28 at 2:34 PM
$ADXN blah speech nothing burger, 
0 · Reply
mikekaren
mikekaren Aug. 28 at 2:14 PM
$ADXN Fed is speaking this morning and the market is listening closely. So far the message sounds cautious on inflation and rates, so expect some volatility. I’m watching the Nasdaq, Treasury yields and especially the chips. Don’t let the first move fool you — let the market digest the comments first. Could get interesting this morning.
0 · Reply
mikekaren
mikekaren Aug. 28 at 1:08 PM
$ADXN I went digging through CEO Tim Dyer’s disclosed ownership history looking specifically for insider selling. I couldn’t find evidence of him dumping his personal ADXN shares during the recent period. The filings show his core share position remained intact. Important distinction: the company raising capital/selling treasury shares is NOT the same thing as the CEO personally selling his stake.Not saying this guarantees anything again about the upcoming results, but with everything we’ve been watching, I’d rather see the CEO holding than heading for the exit.
0 · Reply
mikekaren
mikekaren Aug. 28 at 11:07 AM
$ADXN I went through the new 13D instead of just looking at the headline numbers. Dyer reports 16.85M ordinary shares owned, plus 2.25M shares underlying options currently exercisable. Remember, 120 ordinary shares = 1 ADXN ADS, so those option numbers aren’t 2.25M Nasdaq shares. The options are compensation and have a CHF 0.05 exercise price. Most importantly, the filing says no share transactions by Dyer in the last 60 days other than what’s disclosed. Not saying this guarantees anything — but I don’t see the CEO dumping into the recent move. To me, that’s a positive.
0 · Reply
Golferhack12
Golferhack12 Aug. 27 at 8:13 PM
$ADXN do we know what price they sold the shares at today they raised 2.8 million does anybody know I can't see any press release that has the price per share
0 · Reply
mikekaren
mikekaren Aug. 26 at 2:09 PM
$ADXN Something my dad taught me a long time ago when I was a kid: always be good to the people around you—it keeps you honest and keeps you humble. I try to carry that into trading too. When I’m fortunate enough to make a profit, I like to leave about 20% of that profit in the stock for the long term. I look at it as leaving a little tip on the table. 😂 Nobody wins every time, and nothing is guaranteed. But when the table treats you well, sometimes you tip the dealer and stay in the game. 🎲 Good luck to everyone holding. Let’s see where this thing takes us. 🤞
0 · Reply
mikekaren
mikekaren Aug. 26 at 1:22 PM
$ADXN holy shit
0 · Reply
mikekaren
mikekaren Aug. 26 at 12:34 PM
$ADXN The important tell is whether real volume shows up as we get closer to the open.
0 · Reply
mikekaren
mikekaren Aug. 26 at 11:09 AM
$ADXN good luck everyone
0 · Reply
flybyme
flybyme Aug. 26 at 9:26 AM
$ADXN @mikekaren all sounds good lets not forget ,it only just collapsed a few days ago from $6. Guys like you have been coming and going here for years with the same old stories.
1 · Reply
mikekaren
mikekaren Aug. 26 at 9:15 AM
$ADXN Sometimes you have to take a little risk to get ahead — as long as it’s a risk you can afford to take. A little courage, a little patience, and hopefully a little luck on our side. 🤞🍀
0 · Reply
mikekaren
mikekaren Aug. 26 at 9:11 AM
$ADXN This is how I keep myself from getting an ulcer watching ADXN. 😂 A little shit talking is cheaper than therapy.
0 · Reply
mikekaren
mikekaren Aug. 26 at 9:08 AM
$ADXN Come on people, where’s the excitement? 😂 Sometimes a little shit talking is good for the soul. Stock’s moving — let’s hear some noise!
0 · Reply
mikekaren
mikekaren Aug. 26 at 9:06 AM
$ADXN Come on people, where’s the excitement? 😂 I’ve seen more action at an empty craps table. Stock’s moving and the comment section is taking a nap.
0 · Reply
mikekaren
mikekaren Aug. 26 at 8:56 AM
$ADXN Interesting action early this morning. Up double digits premarket and, more importantly, it’s holding much of the initial move instead of immediately giving it back. I’m watching the $4.40–$4.43 area closely. A break and hold there with increasing volume would make things a lot more interesting. The short-term 3m/5m/15m momentum indicators are starting to turn bullish, but volume still needs to confirm it. Let’s see what happens when more traders wake up.
0 · Reply
mikekaren
mikekaren Aug. 26 at 8:44 AM
$ADXN The Setup: The pre-market gap-up to $4.24 on 10k+ volume is the equivalent of the shooter rolling a couple of sweet numbers in a row. The whole table is screaming, people are high-fiving, and the hype is completely infectious. 🙌📈
0 · Reply
focafoca99
focafoca99 Aug. 26 at 8:42 AM
$ADXN announced a $2.8M ATM offering, extending its cash runway to Q4 2027.
0 · Reply
mikekaren
mikekaren Aug. 26 at 8:35 AM
$ADXN "I am absolutely adding to my bag this morning. Look at the tape—over 10,000 shares traded in early pre-market when the daily average is barely 4,500. The smart money and retail momentum are converging on the exact news we called out. The trend is my friend here, and I'm not missing the boat while this tiny float is actively igniting."
0 · Reply